A detailed history of Fortitude Family Office, LLC transactions in Novartis Ag stock. As of the latest transaction made, Fortitude Family Office, LLC holds 320 shares of NVS stock, worth $31,065. This represents 0.01% of its overall portfolio holdings.

Number of Shares
320
Previous 53 503.77%
Holding current value
$31,065
Previous $5.64 Million 552.36%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$106.13 - $120.89 $28,336 - $32,277
267 Added 503.77%
320 $36.8 Million
Q4 2023

Jan 12, 2024

BUY
$92.27 - $101.54 $4,890 - $5,381
53 New
53 $5.35 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.